Evidence map›Paper›PMID 41244338›Full record

ArticleBioengineering & translational medicine2025

Enhanced Schwann cell differentiation of skin-derived neural crest-like stem cells through the synergistic action of SOX10 and immobilized NRG1 signaling.

Ashis Kumar Podder, Pihu Mehrotra, Pedro Lei, Stelios T Andreadis

Abstract read
In one paragraph

Article in Bioengineering & translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ashis Kumar PodderDepartment of Chemical and Biological Engineering University at Buffalo, The State University of New York (SUNY) Buffalo New York USA.ORCID https://orcid.org/0000-0001-9082-7025
Pihu MehrotraDepartment of Chemical and Biological Engineering University at Buffalo, The State University of New York (SUNY) Buffalo New York USA.
Pedro LeiDepartment of Chemical and Biological Engineering University at Buffalo, The State University of New York (SUNY) Buffalo New York USA.
Stelios T AndreadisDepartment of Chemical and Biological Engineering University at Buffalo, The State University of New York (SUNY) Buffalo New York USA.

Funding

Programmable Hydrogels for Optimized Human Oligodendrocyte Transplantation in Demyelinating DiseaseR01NS130130 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Stelios T. Andreadis, Fraser James Sim · 2023 to 2026
$2.4M
NINDS NIH HHS R01 NS130130
6 · The paper itself

Abstract

Human skin-derived neural crest (NC)-like stem cells present a highly accessible, autologous source of multipotent cells, with the potential to differentiate into a variety of cell types, including Schwann cells (SCs). However, these cells quickly lose their stem-like characteristics in vitro and eventually limit their ability to form functional SCs. To overcome this, we investigated SOX10 upregulation, the key regulator of NC formation and multipotency, using both small chemical (Forskolin and RepSox) treatment and genetic modification. Remarkably, SOX10 upregulation highly increased SC gene expression instead of NC markers, though Forskolin-RepSox also triggered melanocytic and smooth muscle gene markers alongside reduced NC genes. In contrast, genetic SOX10 upregulation enhanced both SOX10 and NC gene expression without inducing alternative lineages. Continuous SOX10 expression was necessary for increased SC protein markers, and differentiating SOX10-overexpressing cells on immobilized NRG1 further enhanced SC markers and induced a distinct, elongated morphology typical for myelinating SCs. Therefore, this study introduces a rapid, efficient method to derive SC-like cells from the skin-derived NCs, highlighting their potential in regenerative medicine for cell therapy and disease modeling applications.

Indexed as

autologous Schwann cellscell therapyneural crest cellsNRG1peripheral nerve repairSchwann differentiationSOX10

Identifiers

PMID41244338
PMCPMC12617549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.